Formosa Laboratories (Taiwan) Insiders
| 4746 Stock | TWD 71.30 0.90 1.25% |
Formosa Laboratories employs about 23 people. The company is managed by 6 executives with a total tenure of roughly 54 years, averaging almost 9.0 years of service per executive, having 3.83 employees per reported executive. Recap of Formosa Laboratories' management performance can provide insight into the venture performance.
| ChenYu Cheng Chairman Pres Chairman |
Formosa |
Formosa Laboratories Management Team Effectiveness
Formosa Laboratories' management efficiency ratios could be used to measure how well Formosa Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Formosa Laboratories Workforce Comparison
Formosa Laboratories is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 132. Formosa Laboratories retains roughly 23.0 in number of employees claiming about 17% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Formosa Laboratories Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Formosa Laboratories Price Series Summation is a cross summation of Formosa Laboratories price series and its benchmark/peer.
Formosa Laboratories Notable Stakeholders
A Formosa Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Formosa Laboratories often face trade-offs trying to please all of them. Formosa Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Formosa Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| ChenYu Cheng | Pres Chairman | Profile | |
| Chien Lin | VP Department | Profile | |
| S BS | VP Sales | Profile | |
| Michelle Lo | VP Fin | Profile | |
| Jinnyuan Lin | Assistant Investment | Profile | |
| C Yang | Chief Officer | Profile |
About Formosa Laboratories Management Performance
The success or failure of an entity such as Formosa Laboratories often depends on how effective the management is. Formosa Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Formosa management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Formosa management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients and UV-filters worldwide. The company was founded in 1995 and is based in Taoyuan, Taiwan. FORMOSA LABORATORIES operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
Please note, the imprecision that can be found in Formosa Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Formosa Laboratories. Check Formosa Laboratories' Beneish M Score to see the likelihood of Formosa Laboratories' management manipulating its earnings.
Formosa Laboratories Workforce Analysis
Traditionally, organizations such as Formosa Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Formosa Laboratories within its industry.Formosa Laboratories Manpower Efficiency
Return on Formosa Laboratories Manpower
| Revenue Per Employee | 136.6M | |
| Revenue Per Executive | 523.7M | |
| Net Income Per Employee | 54.3M | |
| Net Income Per Executive | 208.2M | |
| Working Capital Per Employee | 12M | |
| Working Capital Per Executive | 46.2M |
Additional Tools for Formosa Stock Analysis
When running Formosa Laboratories' price analysis, check to measure Formosa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Formosa Laboratories is operating at the current time. Most of Formosa Laboratories' value examination focuses on studying past and present price action to predict the probability of Formosa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Formosa Laboratories' price. Additionally, you may evaluate how the addition of Formosa Laboratories to your portfolios can decrease your overall portfolio volatility.